CROX Stock Analysis: Crocs | NASDAQ
Footwear & Accessories | NASDAQ, USA | Market Cap: 5.523m USD | 12M Return: 43.5% | US2270461096 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 134M
EPS Trend: 30.1%
Qual. Beats: 16
Rev. Trend: 49.8%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Crocs, Inc. (NASDAQ: CROX) is a U.S.-based casual lifestyle footwear and accessories company that designs, manufactures, markets, and distributes products for men, women, and kids through two core brands: Crocs and HEYDUDE. Founded in 1999 and headquartered in Broomfield, Colorado, the company has been publicly traded since its 2006 IPO.
The companys product range spans a wide variety of casual footwear categories, including clogs, sandals, loafers, sneakers, slides, slippers, boots, and flats, complemented by accessories such as totes, backpacks, socks, and bag charms. Crocs sells through a diversified omnichannel distribution model that includes wholesalers, branded retail stores, e-commerce sites, third-party marketplaces, outlet stores, and kiosks or store-in-store locations, both domestically and internationally.
Operating within the Consumer Discretionary sectors footwear sub-industry, Crocs pursues a multi-brand strategy, combining its flagship Crocs label with the HEYDUDE brand (acquired in 2022) to broaden its appeal across consumer segments and price points.
- HEYDUDE brand revenue declines on softer demand and integration headwinds
- Vietnam manufacturing exposure raises tariff risk concerns
- Crocs brand faces classic clog saturation in core North American market
| Net Income: 593.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -1.10 > 1.0 |
| NWC/Revenue: 8.79% < 20% (prev 9.35%; Δ -0.56% < -1%) |
| CFO/TA 0.18 > 3% & CFO 762.6m > Net Income 593.4m |
| Net Debt (1.90b) to EBITDA (927.7m): 2.05 < 3 |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.2m) vs 12m ago -10.07% < -2% |
| Gross Margin: 57.47% > 18% (prev 59.36%; Δ -1.89% > 0.5%) |
| Asset Turnover: 92.08% > 50% (prev 92.99%; Δ -0.91% > 0%) |
| Interest Coverage Ratio: 6.81 > 6 (EBIT TTM 846.2m / Interest Expense TTM 124.3m) |
| A: 0.08 (Total Current Assets 1.08b - Total Current Liabilities 728.0m) / Total Assets 4.36b |
| B: 0.88 (Retained Earnings 3.82b / Total Assets 4.36b) |
| C: 0.19 (EBIT TTM 846.2m / Avg Total Assets 4.40b) |
| D: 0.47 (Book Value of Equity 1.38b / Total Liabilities 2.97b) |
| Altman-Z'' = 5.18 = AAA |
| DSRI: 1.04 (Receivables 453.2m/446.1m, Revenue 4.05b/4.14b) |
| GMI: 1.03 (GM 59.36% / 57.47%) |
| AQI: 1.00 (AQ_t 0.62 / AQ_t-1 0.62) |
| SGI: 0.98 (Revenue 4.05b / 4.14b) |
| TATA: -0.04 (NI 593.4m - CFO 762.6m) / TA 4.36b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 13, 2026, the stock is trading at USD 116.90 with a total of 987,446 shares traded. Over the past week, the price has changed by -1.09%, over one month by +4.85%, over three months by -10.39% and over the past year by +43.45%.
Current recommended Stop Loss: 112.30 (which is 3.9% or 1.1 ATR below the current price).
Crocs has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold CROX.
- StrongBuy: 5
- Buy: 2
- Hold: 7
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 138.3 | 18.3% |
P/E Trailing = 10.5302
P/E Forward = 8.2169
P/S = 1.3621
P/B = 4.315
P/EG = 1.3926
Revenue TTM = 4.05b USD
EBIT TTM = 846.2m USD
EBITDA TTM = 927.7m USD
Long Term Debt = 1.31b USD (from longTermDebt, last quarter)
Short Term Debt = 90.1m USD (from shortTermDebt, last quarter)
Debt = 2.07b USD (from shortLongTermDebtTotal, last quarter) + Leases 381.5m
Net Debt = 1.90b USD (calculated: Debt 2.07b - CCE 170.3m)
Enterprise Value = 7.42b USD (5.52b + Debt 2.07b - CCE 170.3m)
Interest Coverage Ratio = 6.81 (Ebit TTM 846.2m / Interest Expense TTM 124.3m)
EV/FCF = 10.54x (Enterprise Value 7.42b / FCF TTM 704.6m)
FCF Yield = 9.49% (FCF TTM 704.6m / Enterprise Value 7.42b)
FCF Margin = 17.38% (FCF TTM 704.6m / Revenue TTM 4.05b)
Net Margin = 14.63% (Net Income TTM 593.4m / Revenue TTM 4.05b)
Gross Margin = 57.47% ((Revenue TTM 4.05b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Gross Margin QoQ = 59.41% (prev 56.75%)
Tobins Q-Ratio = 1.70 (Enterprise Value 7.42b / Total Assets 4.36b)
Interest Expense / Debt = 6.00% (Interest Expense 124.3m / Debt 2.07b)
Taxrate = 21.86% (166.0m / 759.4m)
NOPAT = 661.2m (EBIT 846.2m * (1 - 21.86%))
Current Ratio = 1.49 (Total Current Assets 1.08b / Total Current Liabilities 728.0m)
Debt / Equity = 1.50 (Debt 2.07b / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 2.05 (Net Debt 1.90b / EBITDA 927.7m)
Debt / FCF = 2.70 (Net Debt 1.90b / FCF TTM 704.6m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.48% (Net Income 593.4m / Total Assets 4.36b)
RoE = 43.41% (Net Income TTM 593.4m / Total Stockholder Equity 1.37b)
RoCE = 31.63% (EBIT 846.2m / Capital Employed (Equity 1.37b + L.T.Debt 1.31b))
RoIC = 18.64% (NOPAT 661.2m / Invested Capital 3.55b)
WACC = 8.74% (E(5.52b)/V(7.59b) * Re(10.26%) + D(2.07b)/V(7.59b) * Rd(6.00%) * (1-Tc(0.22)))
Discount Rate = 10.26% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.28 | Cagr: -8.36%
[DCF] Terminal Value 72.81% ; FCFF base≈730.3m ; Y1≈681.9m ; Y5≈624.5m
[DCF] Fair Price = 153.6 (EV 9.26b - Net Debt 1.90b = Equity 7.36b / Shares 47.9m; r=8.74% [WACC]; 5y FCF grow -8.36% → 2.50% )
EPS Correlation: 30.12 | EPS CAGR: 1.16% | SUE: 1.64 | # QB: 16
Revenue Correlation: 49.83 | Revenue CAGR: 0.77% | SUE: 2.46 | # QB: 4
EPS current Quarter (2026-09-30): EPS=3.30 | Chg30d=-0.00% | Revisions=-81% | Analysts=14
EPS current Year (2026-12-31): EPS=13.95 | Chg30d=+0.10% | Revisions=+83% | GrowthEPS=+11.5% | GrowthRev=+1.5%
EPS next Year (2027-12-31): EPS=14.95 | Chg30d=+0.16% | Revisions=-38% | GrowthEPS=+7.1% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: -3% (up=16, down=17)